I’m an early career researcher working to build my portfolio in the genomics field, with a particular interest in cancer and rare disease genetics. My research focuses on understanding how inherited and acquired genetic variants contribute to diseases like myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and neurodevelopmental disorders.

During my PhD (2020–2024), I investigated post-zygotic mutations in neurodevelopmental disorder cohorts, contributing to the growing field of mosaicism in human disease.

My current research at SAHMRI focuses on:

• Somatic mutations in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) using targeted gene panels.
• Germline predisposition in therapy-related MDS.
• Functional validation of novel variants discovered in patient cohorts.

I'm passionate about translating complex genomic data into meaningful clinical insights. My goal is to help improve diagnostics, guide treatment decisions, and contribute to more personalised approaches in cancer care.